$Syros Pharmaceuticals (SYRS.US)$
Billy called the .09-.10 drop 4 hours ago and you might want to hear what he says about the future!
https://youtu.be/hvUeeyvSMR8?si=QoK1_UD2jccx-o07

$Syra Health (SYRA.US)$
8-k filed beating earnings.

$Leverage Shares 2x Long TSLA Daily ETF (TSLG.US)$ $Avalo Therapeutics (AVTX.US)$ $Telesat (TSAT.US)$ $Lytus Technologies Holdings (LYT.US)$ $Sonoma Pharmaceuticals (SNOA.US)$ $Paymentus Holdings (PAY.US)$ $Bioventus (BVS.US)$ $LifeMD (LFMD.US)$ $Ramaco Resources-A (METC.US)$ $Myomo (MYO.US)$ $Hesai (HSAI.US)$ $Syros Pharmaceuticals (SYRS.US)$ $Tenon Medical (TNON.US)$ $2seventy bio (TSVT.US)$ $Raytech Holding (RAY.US)$ 📊⚡️📊

$Vanda Pharmaceuticals (VNDA.US)$ silent 🚀

$Syros Pharmaceuticals (SYRS.US)$ With 2/3 a BILLION strong, unite our cause and SQUEEZE this mf until close .  VISUALIZE  with confidence the stock climbing skyward (see it on the screen in front of you ).  Buy the ask knowing you  WILL make a profit.  POWER to the people UNITED!!!
This is the path of success .

$Cutera (CUTR.US)$ i would have been extremely depressed if i didnt sell this sht at 0.245 coz i put alot of money in it.. THE GOAL is to sell immediately your instincts tells you to.. SPIRIT DONT LIE.. dont let emotions (what you think) or what someone else post to make decisions.. NOBODY IS SURE ON WHAT NEXT.. just go in on high volatile stock and aim that sht right. you can make a lot of profit in 30secs to 3mins.. PLAY THE GAME.. take profit always

$Syra Health (SYRA.US)$ Press Release: Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY
Dow Jones· 4 mins ago
Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY
CARMEL, Ind., March 11, 2025
2024 Population Health Revenue Acceleration to 132% YoY
Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains
Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth
A conference call will be h...

$Syra Health (SYRA.US)$
Syra Health's 45% revenue growth to $8.0 million demonstrates strong business momentum in a challenging healthcare market. The standout performer is their Population Health segment, which more than doubled with 132% YoY growth and accelerated to 285% growth in Q4. This strategic shift toward higher-margin business units is already showing significant operational improvements, evidenced by Q4 net losses being cut nearly in half year-over-year.
The company...